Emerging Regulatory Issues for Human Stem Cell Medicine(1)

The regulation of stem cell research is an issue that has drawn much comment, criticism and even judicial arbitration in recent years. An emerging issue, addressed in this article, is how the fruits of that research-stem cell medicine-are likely to be regulated en route from lab to market. Taking ac...

Descripción completa

Detalles Bibliográficos
Autores principales: Liddell, Kathleen, Wallace, Susan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2005
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5424918/
http://dx.doi.org/10.1186/1746-5354-1-1-54
_version_ 1783235212823494656
author Liddell, Kathleen
Wallace, Susan
author_facet Liddell, Kathleen
Wallace, Susan
author_sort Liddell, Kathleen
collection PubMed
description The regulation of stem cell research is an issue that has drawn much comment, criticism and even judicial arbitration in recent years. An emerging issue, addressed in this article, is how the fruits of that research-stem cell medicine-are likely to be regulated en route from lab to market. Taking account of the ethical, legal, social and safety issues raised by stem cell medicine and the goals of governance, the article explains the relevant regulatory instruments (e.g. the draft UK Stem Cell Bank Code, the EU Directive on Human Tissue, the EU Directives on medical products and devices, and the Human Tissue Act 2004) and critically examines the framework they provide.
format Online
Article
Text
id pubmed-5424918
institution National Center for Biotechnology Information
language English
publishDate 2005
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-54249182017-05-16 Emerging Regulatory Issues for Human Stem Cell Medicine(1) Liddell, Kathleen Wallace, Susan Genom Soc Policy Article The regulation of stem cell research is an issue that has drawn much comment, criticism and even judicial arbitration in recent years. An emerging issue, addressed in this article, is how the fruits of that research-stem cell medicine-are likely to be regulated en route from lab to market. Taking account of the ethical, legal, social and safety issues raised by stem cell medicine and the goals of governance, the article explains the relevant regulatory instruments (e.g. the draft UK Stem Cell Bank Code, the EU Directive on Human Tissue, the EU Directives on medical products and devices, and the Human Tissue Act 2004) and critically examines the framework they provide. Springer Berlin Heidelberg 2005-02-15 /pmc/articles/PMC5424918/ http://dx.doi.org/10.1186/1746-5354-1-1-54 Text en © ESRC Genomics Network 2005
spellingShingle Article
Liddell, Kathleen
Wallace, Susan
Emerging Regulatory Issues for Human Stem Cell Medicine(1)
title Emerging Regulatory Issues for Human Stem Cell Medicine(1)
title_full Emerging Regulatory Issues for Human Stem Cell Medicine(1)
title_fullStr Emerging Regulatory Issues for Human Stem Cell Medicine(1)
title_full_unstemmed Emerging Regulatory Issues for Human Stem Cell Medicine(1)
title_short Emerging Regulatory Issues for Human Stem Cell Medicine(1)
title_sort emerging regulatory issues for human stem cell medicine(1)
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5424918/
http://dx.doi.org/10.1186/1746-5354-1-1-54
work_keys_str_mv AT liddellkathleen emergingregulatoryissuesforhumanstemcellmedicine1
AT wallacesusan emergingregulatoryissuesforhumanstemcellmedicine1

Ejemplares similares